Normunity is a biotechnology company developing anti-cancer therapies that target novel tumor-specific mechanisms to engage T cells and suppress immune evasion in solid tumors.

Light Horse Therapeutics develops small molecule therapeutics using a proprietary platform that identifies novel functional domains in disease-critical targets.